Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- Loxo-Btk-21050-Pirtobrutinib-Rba No ClinicalTrials.gov identifier reported
- Loxo-Fg3-23003-Ph1-Fgfr3-Adme No ClinicalTrials.gov identifier reported
- Loxo-Idh-21004-Ph1-Idh1-Pilot Fe + Ppi No ClinicalTrials.gov identifier reported
- Loyola_Shea_Body_Clinical_MR No ClinicalTrials.gov identifier reported
- LP2 Metal Concentration No ClinicalTrials.gov identifier reported
- LP352-106: DDI study with Carbamazepine No ClinicalTrials.gov identifier reported
- LP352-111: Human abuse liability study No ClinicalTrials.gov identifier reported
- LP-935509 No ClinicalTrials.gov identifier reported
- Lp(a) and ASCVD risk in high-risk adults without a prior event No ClinicalTrials.gov identifier reported
- Lp(a) and risk for cardiovascular events by race/ethnicity among adults with chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. No ClinicalTrials.gov identifier reported
- Lp(a) and risk for Recurrent CV events among Black and White Adults with a History of CVD in REGARDS No ClinicalTrials.gov identifier reported
- Lp(a) and risk for Recurrent CV events among Black and White Adults witha History of CVD in REGARDS No ClinicalTrials.gov identifier reported
- Lp(a) lit review No ClinicalTrials.gov identifier reported
- LPS-PAS Flex Mobile Bearing Knee No ClinicalTrials.gov identifier reported
- Lr-303 No ClinicalTrials.gov identifier reported
- LRF Research Grant No ClinicalTrials.gov identifier reported
- LRTI Secondary Analysis for RSV and Hmpv No ClinicalTrials.gov identifier reported
- LSD1 and MEK Inhibitor Combination in Human and Mouse Xenograft Mouse Models of Small Cell Lung Cancer cancer No ClinicalTrials.gov identifier reported
- LSI (Lesion Index) Workflow Observational Study No ClinicalTrials.gov identifier reported
- LSI (Lesion Index) Workflow Post-Market Observational Study NCT03906461
- LSI (Lesion Index) Workflow Post-Market Observational Study No ClinicalTrials.gov identifier reported
- LSI Workflow NCT03906461
- LS PersAFone No ClinicalTrials.gov identifier reported
- LSR Asl NCT00955708
- LSS-Latino Semaglutide Study No ClinicalTrials.gov identifier reported
- LSS of 4 Site NCT01596595
- Lt-001 No ClinicalTrials.gov identifier reported
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma No ClinicalTrials.gov identifier reported
- LTCF No ClinicalTrials.gov identifier reported
- LTHC No ClinicalTrials.gov identifier reported
- Ltos No ClinicalTrials.gov identifier reported
- Ltse No ClinicalTrials.gov identifier reported
- LTX Av Cl002301 No ClinicalTrials.gov identifier reported
- Ltx-Av Pas No ClinicalTrials.gov identifier reported
- Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/Paraganglioma No ClinicalTrials.gov identifier reported
- Lu Af28996 in Participants With Parkinson's Disease (PD) NCT04291859
- Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) NCT04597450
- Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) NCT04597450
- Lubeck Project No ClinicalTrials.gov identifier reported
- Lucent No ClinicalTrials.gov identifier reported
- Lucent Design Research No ClinicalTrials.gov identifier reported
- Lucentis Dosing Retreatment No ClinicalTrials.gov identifier reported
- Lucentis Dosing Retreatment No ClinicalTrials.gov identifier reported
- Lucentis Fsv4 Lad Amd Ladder No ClinicalTrials.gov identifier reported
- Lucent Lateral No ClinicalTrials.gov identifier reported
- Lucent Lateral Design Research No ClinicalTrials.gov identifier reported
- Lucent XP No ClinicalTrials.gov identifier reported
- Lucent XP ARC Design Research No ClinicalTrials.gov identifier reported
- Lucent XP Design Research No ClinicalTrials.gov identifier reported
- Lucira in Immunocompromised No ClinicalTrials.gov identifier reported